SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-031496
Filing Date
2024-03-14
Accepted
2024-03-14 16:15:22
Documents
13
Period of Report
2024-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K allk-20240314.htm   iXBRL 8-K 41839
2 EX-99.1 allk-ex99_1.htm EX-99.1 180637
  Complete submission text file 0000950170-24-031496.txt   347074

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT allk-20240314.xsd EX-101.SCH 25027
15 EXTRACTED XBRL INSTANCE DOCUMENT allk-20240314_htm.xml XML 4741
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 24750322
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)